Ulrike Osowski

Multiple sclerosis in Germany: data analysis of administrative prevalence and healthcare delivery in the statutory health system

Ariane Höer, G. Schiffhorst, Anne Zimmermann et al. · BMC Health Services Research · 2014 · 48 citations · Full text

Pharmacy, Health Systems, Neurology +10

Cost-Effectiveness of Targeted Therapy With Cetuximab in Patients With K-ras Wild-Type Colorectal Cancer Presenting With Initially Unresectable Metastases Limited to the Liver in a German Setting

Christian Asseburg, Martin Frank, Claus‐Henning Köhne et al. · Clinical Therapeutics · 2011 · 36 citations

Medicine, Oncology, Pharmacoeconomics +12

Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims data

Christoph Ohlmeier, Holger Gothe, Judith Haas et al. · PLoS ONE · 2020 · 34 citations · Full text

Medicine, Insurance, Neurology +17

Patient adherence to subcutaneous IFN beta-1a injections using the RebiSmart<sup>®</sup> injection device: a retrospective real-world study among Dutch and German patients with multiple sclerosis

Marieke Krol, Gert de Voer, Ulrike Osowski · Patient Preference and Adherence · 2017 · 13 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +8

Treatment of congestive heart failure – current status of use of digitoxin

G. G. Belz, Kerstin Breithaupt‐Grögler, Ulrike Osowski · European Journal of Clinical Investigation · 2001 · 12 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17